Answers are grounded in this paper and cite their sources.
Bone‐metastasis atlases reveal recurrent remodeling, but internally stable representations may fail across cohorts or controls. We evaluated a patient‐aware workflow separating discovery stability, technical reconstruction, biological comparison, and spatial organization. Discovery included 107,886 cells from 42 prostate and renal samples from 18 patients, with 11 complete anatomical triplets. Under fixed historical labels, paired compositional sensitivities retained nine myeloid and T/natural‐killer state directions; alternative annotations changed some directions and projection coverage. A historically derived 81‐gene list failed its archived external directional criterion, and a three‐ecotype representation failed its external criteria. A 26‐feature multiblock Axis1, comprising broad‐lineage, myeloid and T/natural‐killer compositions, explained 54.17% of discovery variance. Post‐review comparisons showed almost identical ordering to unbalanced PC1 (Spearman rho, 0.996) and similar patient‐held‐out reconstruction errors (0.489461 vs. 0.490098). Involved‐minus‐distal marrow differences were smaller than solid metastatic‐tissue‒marrow differences; patient‐and‐anatomy‐adjusted associations with mitochondrial percentage and predicted doublet removal left quality control‐related variation unresolved. In GSE266330, 41 bone‐metastasis patients and five healthy‐marrow donors separated on Axis1 but shared no author‐defined sequencing label. This source‐confounded contrast could not establish a disease effect independently of source or replace the unmet matched‐normal‐bone rule (one of two patients positive). Four linked mouse sections retained positive spatial contrasts under mapping sensitivities, although some contrast magnitudes were sensitive and independent animal counts were unknown. These findings support an inspectable representation stress‐testing workflow and an anatomically organized sample‐context coordinate, not a demonstrated methodological advantage, universal bone‐metastasis state, mechanism, or predictor.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: